(SISI) – Company Press Releases
-
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
-
Shineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute Test
-
Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company
-
Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce
-
Shineco Subsidiary’s ‘Cardiac 5-Minute Test’ Passes Quality Inspection by China Regulator NMPA
-
Shineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus Group
-
Shineco, Inc. Subsidiary Receives Prior Approval Supplement from the NMPA Jiangsu Bureau for the Marketing Approval of “Cardiac 5-Minute Test”
-
Shineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling Device
-
Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany
-
Shineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing Industry
-
Shineco, Inc. Announces Director Change
-
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million
-
Shineco, Inc. Announces Board and Officer Changes
-
Shineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition
-
Shineco, Inc. to Build Its First Tumor Classification Diagnosis and Treatment Center in Weifang City, Shandong Province
-
Shineco, Inc. Announces New Website Launch
-
Shineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor Patients
-
Shineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical Devices
-
Shineco, Inc. Enters Into Cooperation Agreement to Jointly Manufacture PET and Explore High-end Medical Imaging Devices Field
-
Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant
-
Shineco, Inc. Enters Into Share Transfer Agreements to Acquire 51% Equity Interest in Xiang Peng You Kang (Beijing) Technology Co., Ltd.
-
Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD
-
Shineco, Inc. Intends to Acquire a Controlling Interest of Xiang Peng You Kang (Beijing) Technology Co., Ltd., a Healthcare Services Company
-
Shineco, Inc. Explores Medical Aesthetic Industry by Entering into MOU with Dragon Pride Limited
Back to SISI Stock Lookup
